To continue reading this article, you must have a paid membership.
Existing paying members, please log in to access the full story.
During yesterday’s Q2 earnings call, Xerox CEO Steve Bandrowczak fielded an analyst’s question on the impact to the company of the recent ban on Ninestar imports to the US.